The cost-effectiveness of smoking cessation support delivered by mobile phone text messaging: Txt2stop

European Journal of Health Economics

Volumn 14, Issue 5, 2013, Pages 789-797

  Guerriero, Carla ^a   Cairns, John ^a   Roberts, Ian ^a   Rodgers, Anthony ^b   Whittaker, Robyn ^c   Free, Caroline ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Economic evaluation; Smoking cessation aid; Text message

Indexed keywords

AGE DISTRIBUTION; ARTICLE; CEREBROVASCULAR ACCIDENT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; COST; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; ECONOMIC EVALUATION; GENDER; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH STATUS; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; LIFE EXTENSION; LUNG CANCER; MOBILE PHONE; NATIONAL HEALTH SERVICE; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; SENSITIVITY ANALYSIS; SIMULATION; SMOKING CESSATION; STUDY; TEXT MESSAGING; UNITED KINGDOM;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; COST-BENEFIT ANALYSIS; FEMALE; FINANCING, PERSONAL; GREAT BRITAIN; HEALTH STATUS INDICATORS; HUMANS; MALE; MARKOV CHAINS; MIDDLE AGED; QUALITY-ADJUSTED LIFE YEARS; SEX DISTRIBUTION; SMOKING CESSATION; SOCIAL SUPPORT; TEXT MESSAGING;

EID: 84887282083     PISSN: 16187598     EISSN: 16187601     Source Type: Journal    
DOI: 10.1007/s10198-012-0424-5     Document Type: Article

References (36)

1. Free, C., Knight, R., Rodgers, A., Whittaker, A. R., Cairns, J., Edwards, P., Roberts, I.: A randomised controlled trial of mobile phone based smoking cessation support: txt2stop. Lancet 378, 49-55 (2011)
2. Free, C., Whittaker, R., Knight, R., Abramsky, T., Rodgers, A., Roberts, I. G.: Txt2stop: a pilot randomised controlled trial of mobile phone-based smoking cessation support. Tob. Control 18, 88-91 (2009)
3. Rodgers, A., Corbett, T., Bramley, D., Riddell, T., Wills, M., Lin, R. B., Jones, M.: Do u smoke after txt? Results of a randomised trial of smoking cessation using mobile phone text messaging. Tob. Control 14, 255-261 (2005)
4. HM Government: Healthy lives healthy people: a tobacco control plan for England. (2011)
5. Flack, S., Taylor, M., Trueman, P. A.: Cost-effectiveness of interventions for smoking cessation. York Health Economics Consortium. (2007)
6. Raikou, M., McGuire, A.: Cost-effectiveness of a mass media campaign and a point of sale intervention to prevent the uptake of smoking in children and young people: economic modelling report. LSE Health (2008)
7. US Department of Health and Human Services: The Health Consequences of Smoking: A Report of the Surgeon General. Atlanta: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health (2004)
8. National Institute for Health and Clinical Excellence (NICE): updated guide to the methods of technology appraisal. 29-49 (2008) http://www.nice.org. uk/aboutnice/howwework/devnicetech/techno logyappraisalprocessguides
9. Newman, A. B., Brach, J. S.: Gender gap in longevity and disability in older persons. Epidemiol. Rev. 23, 343-355 (2001)
10. Stapleton, J.: Cigarette smoking prevalence, cessation and relapse. Stat. Methods Med. Res. 7, 187-203 (1998)
11. Etter, J. F., Stapleton, J. A.: Nicotine replacement therapy for longterm smoking cessation: a meta-analysis. Tob. Control 15, 280-285 (2006)
12. Craig, F., Hirani, V. (eds.): Health survey for England, 2009. The NHS Information Centre (2010)
13. West, R.: Background smoking cessation rates in England. http://www.smokinginengland.info/Ref/paper2.pdf
14. Robinson, S., Harris, H.: Smoking and drinking among adults, 2009. Office of National Statistics, London. (2011)
15. Doll, R., Peto, R., Wheatley, K., Gray, R., Sutherland, I.: Mortality in relation to smoking: 40 years' observations on male British doctors. BMJ 309, 901-911 (1994)
16. Forman, D., Stockton, D., Moller, H., Quinn, M., Babb, P., De Angelis, R., Micheli, A.: Cancer prevalence in the UK: results from the EUROPREVAL study. Ann. Oncol. 14, 648-654 (2003)
17. Britton, M.: The burden of COPD in the U. K.: results from the Confronting COPD survey. Respir. Med. 97(Suppl C), S71-S79 (2003)
18. Allender, S., Peto, V., Scarborough, P., Boxer, A., Rayner, M.: Coronary Heart Disease Statistics, 2006 edn
19. Peto, R., Darby, S., Deo, H., Silcocks, P., Whitley, E., Doll, R.: Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies. BMJ 321, 323-329 (2000)
20. Tengs, T. O., Wallace, A.: One thousand health-related quality-oflife estimates. Med. Care 38, 583-637 (2000)
21. Rutten-Van Molken, M. P., Oostenbrink, J. B., Tashkin, D. P., Burkhart, D., Monz, B. U.: Does quality of life of COPD patients as measured by the generic EuroQol five-dimension questionnaire differentiate between COPD severity stages? Chest 130, 1117-1128 (2006)
22. Tillmann, M., Silcock, J.: A comparison of smokers' and ex-smokers' health-related quality of life. J. Pub. Health Med. 19, 268-273 (1997)
23. Cancer of the Lung, First Series. [http://hcna.radcliffeoxford]
24. Reducing Brain Damage: Faster Access to Better Stroke Care. http://www.nao.org.uk/publications/nao-reports/05-06/0506452.pdf
25. Department of Health: NHS Reference Costs 2005. (2008)
26. NICE: Chronic obstructive pulmonary disease. National clinical guideline on management of chronic obstructive pulmonary disease in adults in primary and secondary care. Thorax 59(supplement 1), 1-232 (2004)
27. Petersen, S., Peto, V., Rayner, M., Leal, J., Luengo-Fernandez, R., Gray, A.: Health Care Costs of CVD and CHD, 2003, United Kingdom (2003)
28. McGhan, W. F., Smith, M. D.: Pharmacoeconomic analysis of smoking-cessation interventions. Am. J. Health-Syst. Pharm. 53, 45-52 (1996)
29. Yudkin, P., Hey, K., Roberts, S., Welch, S., Murphy, M., Walton, R.: Abstinence from smoking eight years after participation in randomised controlled trial of nicotine patch. BMJ 327, 28-29 (2003)
30. Briggs, A., Claxton, K., Sculpher, M.: Decision modelling for health economic evaluation. In: Handbook in Economic Evaluation, Oxford University Press, Oxford (2008)
31. Flack, S., Taylor, M., Trueman, P.: A rapid review of the costeffectiveness of National Health Service treatments for smoking cessation in England. York Health Economics Consortium (2006)
32. Taylor, M.: Economic analysis of interventions for smoking cessation aimed at pregnant women. Supplementary report. York Health Economics Consortium (2009)
33. Arday, D. R., Giovino, G. A., Schulman, J., Nelson, D. E., Mowery, P., Samet, J. M.: Cigarette smoking and self-reported health problems among U. S. high school seniors, 1982-1989. Am. J. Health Promot. 10, 111-116 (1995)
34. Van Baal, P. H., Polder, J. J., De Wit, G. A., Hoogenveen, R. T., Feenstra, T. L., Boshuizen, H. C., Engelfriet, P. M., Brouwer, W. B.: Lifetime medical costs of obesity: prevention no cure for increasing health expenditure. PLoS Med. 5, e29 (2008)
35. Woolacott, N. F., Jones, L., Forbes, C. A., Mather, L. C., Sowden, A. J., Song, F. J., Raftery, J. P., Aveyard, P. N., Hyde, C. J., Barton, P. M.: The clinical effectiveness and cost-effectiveness of bupropion and nicotine replacement therapy for smoking cessation: a systematic review and economic evaluation. Health Technol. Assess. 6, 1-245 (2002)
36. Feenstra, T. L., Hamberg-Van Reenen, H. H., Hoogenveen, R. T., Rutten-Van Molken, M. P.: Cost-effectiveness of face-to-face smoking cessation interventions: a dynamic modeling study. Value Health 8, 178-190 (2005)